See All
05/11/2025
VIDEO: Proteomics International Laboratories Ltd (ASX:PIQ) Interview with Managing Director Dr. Richard Lipscombe
Proteomics set for revenue boost after launching two products
21/10/2025
New noninvasive endometriosis tests are on the rise
16/10/2025
Proteomics International, U of Melbourne, RWH Ink Deal for Endometriosis Test Development – 360Dx
19/05/2025
10/02/2025
February Newsletter 2025
31/12/2023
December Newsletter 2023
10/05/2023
May Newsletter 2023
08/09/20255
Clinical Performance of the PromarkerEso Blood Test For diagnosing Early Stage Esophageal Adenocarcinoma and Barrett’s Esophagus with High-Grade Dysplasia
24/07/2025
Analytical and Clinical Performance of a Novel Immunoassay-Based Test System to Predict Diabetic Kidney Disease
14/07/2025
The Level of Thiol-Oxidised Plasma Albumin Is Elevated Following a Race in Australian Thoroughbred Horses
05/06/2025
A Clinical Validation of a Diagnostic Test for Esophageal Adenocarcinoma Based on a Novel Serum Glycoprotein Biomarker Panel: PromarkerEso
Investor presentation - Bell Potter Healthcare Conference
08/04/2025
Investor Presentation – Morgan Stanley Alpha ex-100 Conference
20/03/2025
Investor Presentation – Broker Meets Biotech
04/02/2025
Investor Presentation – Euroz Hartleys Healthcare Forum
.png?width=297&height=169&name=Frame%20292%20(3).png)
.png?width=297&height=169&name=Frame%20292%20(4).png)
.png?width=297&height=169&name=Frame%20292%20(5).png)
.png?width=297&height=169&name=Frame%20292%20(6).png)
